Johnson & Johnson to Participate in the SVB Securities Global Biopharma Conference

Johnson & Johnson (NYSE: JNJ) will participate in the SVB Securities Global Biopharma Conference on Wednesday, February 15th.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Wednesday, January 18, 2023
Information
Tags: 
Biotechnology, General Health, Health, Pharmaceutical, Medical Supplies, Eastern Time Zone, Oncology, JNJ, Conference, Webcast, Johnson & Johnson, NYSE, Broadcasting
Geotags: 
NEW JERSEY, UNITED STATES, NORTH AMERICA
Organisation: 
JOHNSON & JOHNSON
Stock Symbol: 
NYSE:JNJ
Summary
Key Points: 
  • Johnson & Johnson (NYSE: JNJ) will participate in the SVB Securities Global Biopharma Conference on Wednesday, February 15th.
  • Biljana Naumovic, Worldwide Vice President, Oncology and Peter Lebowitz, Global Therapeutic Head, Oncology will represent the Company in a virtual session scheduled at 1:00 p.m. (Eastern Time).
  • The audio webcast replay will be available approximately 48-hrs after the webcast.
  • View source version on businesswire.com: https://www.businesswire.com/news/home/20230118005064/en/


Johnson & Johnson (NYSE: JNJ) will participate in the SVB Securities Global Biopharma Conference on Wednesday, February 15th. Biljana Naumovic, Worldwide Vice President, Oncology and Peter Lebowitz, Global Therapeutic Head, Oncology will represent the Company in a virtual session scheduled at 1:00 p.m. (Eastern Time).

This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

The audio webcast replay will be available approximately 48-hrs after the webcast.

Copyright: 
Copyright Business Wire 2023